Contact this trialFirst, we need to learn more about you.
Cytokine
Leukine for Parkinson's Disease
Recruiting2 awardsPhase 1
Omaha, Nebraska
This trial is testing the safety of a 24-month regimen of Leukine as a treatment for Parkinson's disease. Clinical signs and symptoms will be measured by personal well-being, physical, and neurological examinations, and blood tests. The investigators will also assess the tolerability of the regimen and the effects of treatment on immune deficits in PD.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.